Assessment of Ovarian Reserve with Anti-Müllerian Hormone: a Comparison of the Predictive Value of Anti-Müllerian Hormone, Follicle-stimulating Hormone, Inhibin B, and Age
Overview
Authors
Affiliations
Objective: The objective of this study was to evaluate basal anti-Müllerian hormone as a marker for ovarian responsiveness to fertility treatment.
Study Design: Frozen basal menstrual cycle day 3 serum samples were evaluated retrospectively for anti-Müllerian hormone, inhibin B, and follicle-stimulating hormone levels in 123 in vitro fertilization cycles (93 patients) and compared with in vitro fertilization records.
Results: Anti-Müllerian hormone values correlated the best with the number of retrieved oocytes (r = 0.539; P < .001) relative to age (r = -0.323; P < .01), follicle-stimulating hormone (r = -0.317; P < .01), inhibin B (P > .05), luteinizing hormone (P > .05), and estradiol (r = -0.190; P < .05). Receiver operating characteristic curve analysis demonstrated that, for the prediction of <4 oocytes retrieved, anti-Müllerian hormone had the largest area under the curve (AUC = 0.81; P = .0001) relative to age (r = 0.74; P = .005), follicle-stimulating hormone (0.71; P = .02), inhibin B (0.66; P = .03), and estradiol (0.54; P > .05). Similarly, for the prediction of >or=15 retrieved oocytes, anti-Müllerian hormone had the largest area under the curve (0.80; P = .0001) relative to age (0.63; P = .02), follicle-stimulating hormone (0.64; P = .005), inhibin B (r = 0.57; P > .05), and estradiol (0.58; P > .05).
Conclusion: Anti-Müllerian hormone correlates better than age, follicle-stimulating hormone, luteinizing hormone, inhibin B, and estradiol with the number of retrieved oocytes. Receiver operating characteristic curves estimated that anti-Müllerian hormone accurately predicts ovarian responsiveness to controlled ovarian stimulation with high sensitivity and specificity.
Salemi F, Jambarsang S, Kheirkhah A, Salehi-Abargouei A, Ahmadnia Z, Hosseini H Syst Rev. 2024; 13(1):303.
PMID: 39695880 PMC: 11657140. DOI: 10.1186/s13643-024-02684-0.
Gutierrez A, Munoz-Perez R, Zapater P, Mira C, Rodriguez A, Sempere-Robles L Front Med (Lausanne). 2024; 11:1374603.
PMID: 38725465 PMC: 11080652. DOI: 10.3389/fmed.2024.1374603.
Xiang P, Yao J, Li X, Zhang M, Hu P, Zhi M J Ovarian Res. 2023; 16(1):34.
PMID: 36750949 PMC: 9903622. DOI: 10.1186/s13048-023-01112-6.
Yan S, Jin W, Ding J, Yin T, Zhang Y, Yang J Aging (Albany NY). 2021; 13(13):17137-17154.
PMID: 33999860 PMC: 8312467. DOI: 10.18632/aging.203032.
Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?.
Wen J, Huang K, Du X, Zhang H, Ding T, Zhang C Front Endocrinol (Lausanne). 2021; 12:626534.
PMID: 33935966 PMC: 8081350. DOI: 10.3389/fendo.2021.626534.